Curaleaf (OTCMKTS:CURLF) Upgraded at Cormark
Cormark upgraded shares of Curaleaf (OTCMKTS:CURLF – Free Report) from a hold rating to a moderate buy rating in a research report released on Monday, Zacks.com reports. Cormark also issued estimates for Curaleaf’s FY2024 earnings at ($0.25) EPS and FY2025 earnings at ($0.18) EPS. Separately, Needham & Company LLC reaffirmed a buy rating and set […]
More Stories
UMB Bank n.a. Sells 291 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
UMB Bank n.a. cut its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 7.1% during...
Capital One Financial Co. (NYSE:COF) Shares Sold by Gateway Investment Advisers LLC
Gateway Investment Advisers LLC reduced its stake in shares of Capital One Financial Co. (NYSE:COF) by 7.3% in the 1st...
Wedmont Private Capital Has $699,000 Stock Holdings in Novartis AG (NYSE:NVS)
Wedmont Private Capital increased its position in Novartis AG (NYSE:NVS – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com...
Patriot Financial Group Insurance Agency LLC Purchases 394 Shares of Truist Financial Co. (NYSE:TFC)
Patriot Financial Group Insurance Agency LLC grew its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by...
RFK Jr. Removes All Members of CDC Vaccine Advisory Panel
By Zachary Stieber All members of the committee that advises the Centers for Disease Control and Prevention are being replaced,...
ICE Sends Back 122 Illegal Immigrants to China
By Aldgra Fredly Some 122 illegal immigrants were deported to China on June 3 as part of the Department of...